3

OWNERSHIP DOCUMENT

Company: GYRE THERAPEUTICS, INC.
Filed: February 15, 2018
Period of Report: February 15, 2018
Accession Number: 0001193805-18-000259

View Document ↗ View on SEC.gov ↗